Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Bruce Wilkoff Added: 1 year ago
Find out what your colleagues are talking about, tune in to our Optimal Management of Cardiac Implantable Electronic Device Infections podcast! Renowned industry experts explore what CIED infections mean for you and your patients. Find out why antibiotics alone do not work and what you can do. Plus, watch our unmissable patients stories episode. Click here to watch the video versions View more
Author(s): Diana Hui Ping Foo Added: 4 days ago
ESC HF 25 - Findings from Heart2Miss suggest a hub-and-spoke model for early heart failure detection can detect patients with pre-HF and HF who were previously undiagnosed, can reduce tertiary center overload and improve novice performance.Dr Diana Foo (Sarawak General Hospital, Kuching, MY) discusses the findings from the Heart2Miss study, investigating a decentralised, community-based, rapid,… View more
Research Area(s) / Expertise: Job title: Head of the Cardiac Department and Electrophysiology Lab
Stylianos Tzeis is the Head of the Cardiac Department and EP Lab in Mitera Hospital, Hygeia Group in Athens, Greece. He is a cardiac electrophysiologist with a clinical and research focus on catheter ablation and cardiac implantable electronic devices. He has authored over 100 papers in peer-reviewed journals. He is a member of the board of the European Heart Rhythm Association and since 2017… View more
Author(s): Domingo Figal Added: 2 years ago
ESC-HFA 2023 — Prof Domingo Pascual Figal (Hospital Clinico Universitario Virgen de la Arrixaca, SP) discusses the DAPA MODA study (NCT04707352). The study aimed to assess the effects of dapagliflozin on cardiac remodeling parameters, particularly LA geometry and function, and biomarkers reflecting pathophysiological pathways. Findings from ESC Heart Failure 2023 revealed that dapagliflozin… View more
Author(s): Marianna Fontana Added: 2 years ago
ESC-HFA 23 — We are joined by Prof Marianna Fontana (University College London, UK), as she outlines the key findings from the phase 3 APOLLO-B study (Alnylam Pharmaceuticals) (NCT03997383). APOLLO-B investigated the use of patisiran, a transthyretin-directed small interfering RNA, in a cohort of patients with cardiac amyloidosis. 360 patients were enrolled in the trial and were randomized 1:1… View more
Job title: Consultant Cardiologist (Sub-specialty interests in Heart Failure and Cardiac Devices)
Dr Ahmed is an editorial board member for Cardiac Failure Review and with her permission, she may be contactedhere. Personal History Dr Fozia Zahir Ahmed was born in Manchester, England. She is a consultant cardiologist at the Manchester Heart Centre, part of Manchester Royal Infirmary, where she specialises in heart failure and cardiac devices.1 Academic History Dr Ahmed… View more